ach year, Digestive Disease Week (DDW) brings together the best clinical, translational, and basic science in the field. It is also an opportunity for many trainees and young investigators to present their work, receive advice from senior investigators, and build their professional networks. At DDW 2016, the American Gastroenterological Association (AGA) recognized 1 member each from 10 Council sections who have committed themselves to training these young investigators and have shown a track record of outstanding research mentorship. Cellular and Molecular Gastroenterology and Hepatology extends our appreciation to the awardees in each section for providing guidance and mentorship to the next generation of researchers.
Cellular and Molecular Gastroenterology (CMG) Section: James R. Goldenring, MD, PhD, AGAF James Goldenring received his AB degree from Harvard College and his MD and PhD degrees from Yale University. After residency training in general surgery from 1986 to 1988 at Yale New Haven Hospital, he completed a postdoctoral fellowship in surgical research as an American College of Surgeons Research Fellow. Dr Goldenring was one of the founding members of the Institute of Molecular Medicine at the Medical College of Georgia. Dr Goldenring is presently the Paul Sanger Professor of Surgery and Professor of Cell and Developmental Biology and Co-Director of the Epithelial Biology Center at Vanderbilt University Medical Center. Dr Goldenring's research spans multiple topics across the broad area of epithelial biology. He has been a leader in the investigation of the specific roles of Rab small guanosine triphosphatases in regulating vesicle trafficking and membrane recycling in polarized cells. Most recently, Dr Goldenring has studied aberrant membrane trafficking in the context of neonatal congenital diarrhea diseases, especially in microvillus inclusion disease and MYO5B knockout mice. Finally, Dr Goldenring has been a leader in the field of gastric cancer research, studying the mechanisms responsible for the induction of metaplasia. His findings have shown that preneoplastic metaplasia (spasmolytic polypeptide-expressing metaplasia) does not arise from professional mucosal stem cells, but rather from transdifferentiation of mature chief cells into a proliferative Center not only provides state-of-the-art care and evaluation for children with motility and functional bowel disorders, but has a well-funded research base, as well as a well-defined educational component that allows the training of the next generation of pediatric gastrointestinal (GI) motility specialists. Dr Nurko has distinguished himself during his long tenure as an academic, NIHfunded clinical researcher, teacher, mentor, and expert in motility and functional disorders of the gastrointestinal tract in children. He is a recognized leader in the field and has participated in many national and international committees and task forces, including being the Chair of the Neonatal/ Toddler Rome IV Committee. Dr Nurko has made major contributions to the understanding of motility and functional GI disorders in children. His clinical and research interests have focused on understanding the pathophysiology and establishing the best approach and treatments for these disorders, and he has been a pioneer in the development and validation of new techniques to study these disorders in the pediatric population.
Imaging and Advanced Technology (IAT) Section: William R.
Brugge, MD, AGAF, FASGE
William Brugge is a teacherclinician in the GI Unit at Massachusetts General Hospital. Dr Brugge's academic and research focus involves the field of advanced endoscopy and he was one of the pioneers in the development of endoscopic ultrasound (EUS). Although EUS originally was designed to simply stage gastrointestinal malignancies, it has evolved into an important diagnostic and therapeutic technique for endoscopists. The application of EUS in the diagnosis, staging, and biopsy of pancreatic malignancies has been a particularly important focus for Dr Brugge, and he has concentrated on the diagnosis and management of pancreatic cystic neoplasms. Dr Brugge led a large multicenter trial, finding that EUS imaging morphology and cyst cytology were relatively nondiagnostic for differentiating between mucinous and serous cystadenomas. The trial showed that cyst fluid tumor markers were the most diagnostic tool and carcinoembryonic antigen was the most accurate marker. Dr Brugge also has examined the possibility that EUS could be used as a treatment of cystic neoplasms. EUS-guided ethanol ablation of cystic neoplasms was developed at Massachusetts General Hospital under his direction. In addition to performing endoscopic research in patients, Dr Brugge evaluates new ablative technologies in an animal laboratory, using endoscopic ultrasound to guide various ablative catheters and agents into the pancreas. Dr Brugge's group has evaluated radiofrequency ablation, photodynamic therapy, ethanol, and chemotherapeutic agents. Lately, they have evaluated confocal endomicroscopy for differentiating between mucinous and nonmucinous cysts. Her research interests center on the normal and abnormal biology of the intestinal epithelium and their relevance to a variety of digestive diseases including inflammatory bowel diseases, infectious diarrheal diseases, and peptic ulcer disease. She has received a number of honors for her research, including the Bowditch and Davenport Lectureships of the American Physiological Society, the Bayliss-Starling Prize Lectureship from the Physiological Society of the United Kingdom and Ireland, and the degree of Doctor of Medical Science, honoris causa, from Queens University Belfast. She has been highly active in professional societies and in scholarly editing, and is a Past President of the American Physiological Society and the current Editor-in-Chief of The Journal of Physiology. She has served on numerous committees for the AGA, including as an elected member of the AGA Institute Council and a member of the Governing Board. She is the author or editor of several books and monographs (including 2 editions of the textbook, "Gastrointestinal Physiology," which also has been translated into Spanish and Portuguese), and more than 200 peer-reviewed journal articles, book chapters, and reviews. In 2006, she was appointed as Dean of the Graduate Division at the University of California San Diego. In this capacity, she serves as a member of the senior academic management team and oversees the recruitment, academic advancement, and climate for more than 5000 masters and doctoral students. Obesity, Metabolism and Nutrition (OMN) Section: Patrick Tso, PhD Patrick Tso is a distinguished career investigator who has mentored numerous predoctoral and postdoctoral trainees, as well as several clinical fellows, and has inspired many to go on as successful independent researchers. He is the Mary Emery Professor of Pathology at the University of Cincinnati. Dr Tso's highly successful career there has included positions such as the Director of the NIH-funded Cincinnati Mouse Metabolic Phenotyping Center and Director of the Center for Lipid Research for 6 years. He was the recipient of the Daniel Drake Medal, the highest honor bestowed to a faculty at the College of Medicine. Dr Tso's
